PJP vs. SPMO
PJP (Invesco Dynamic Pharmaceuticals ETF) and SPMO (Invesco S&P 500 Momentum ETF) are both exchange-traded funds - PJP is a Health & Biotech Equities fund tracking the Dynamic Pharmaceuticals Intellidex Index, while SPMO is a Momentum fund tracking the S&P 500 Momentum Index. Both are passively managed. Over the past 10 years, PJP returned 6.15%/yr vs 20.95%/yr for SPMO. At a 0.45 correlation, their price movements are largely independent. PJP charges 0.58%/yr vs 0.13%/yr for SPMO.
Performance
PJP vs. SPMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PJP achieves a 2.90% return, which is significantly lower than SPMO's 30.35% return. Over the past 10 years, PJP has underperformed SPMO with an annualized return of 6.15%, while SPMO has yielded a comparatively higher 20.95% annualized return.
PJP
- 1D
- 1.20%
- 1M
- 1.29%
- YTD
- 2.90%
- 6M
- 2.29%
- 1Y
- 34.73%
- 3Y*
- 13.31%
- 5Y*
- 7.62%
- 10Y*
- 6.15%
SPMO
- 1D
- 0.50%
- 1M
- 15.36%
- YTD
- 30.35%
- 6M
- 30.51%
- 1Y
- 46.00%
- 3Y*
- 43.04%
- 5Y*
- 24.29%
- 10Y*
- 20.95%
PJP vs. SPMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 2.90% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 11.29% | 4.64% | -1.78% | 15.30% |
SPMO Invesco S&P 500 Momentum ETF | 30.35% | 26.58% | 45.82% | 17.56% | -10.45% | 22.64% | 28.25% | 25.93% | -0.92% | 27.76% |
Correlation
The correlation between PJP and SPMO is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.46 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Oct 13, 2015 | 0.45 |
The correlation between PJP and SPMO shifts across timeframes, from 0.25 (1 year) to 0.48 (10 years), reflecting how their relationship changes across market environments.
PJP vs. SPMO - Sectors Allocation Comparison
Sectors
PJP
SPMO
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
PJP
SPMO
Basic Materials
PJP
-
SPMO
Communication Services
PJP
-
SPMO
Consumer Cyclical
PJP
-
SPMO
Consumer Defensive
PJP
-
SPMO
Energy
PJP
-
SPMO
Financial Services
PJP
-
SPMO
Industrials
PJP
-
SPMO
Real Estate
PJP
-
SPMO
Technology
PJP
-
SPMO
Utilities
PJP
-
SPMO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. SPMO — Risk / Return Rank
PJP
SPMO
PJP vs. SPMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco S&P 500 Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | SPMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.49 | ||
| Sortino ratioReturn per unit of downside risk | -0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.47 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | 3.64 | +0.06 |
| Martin ratioReturn relative to average drawdown | 11.55 | 14.17 | -2.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PJP | SPMO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 2.62 | -0.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 1.27 | -0.79 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | 1.03 | -0.70 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 1.01 | -0.42 |
Drawdowns
PJP vs. SPMO - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, which is greater than SPMO's maximum drawdown of -30.95%. Use the drawdown chart below to compare losses from any high point for PJP and SPMO.
Loading charts...
Drawdown Indicators
| PJP | SPMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -30.95% | -6.11% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | -12.70% | +3.26% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | -20.13% | +3.86% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -22.74% | +5.23% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | -30.95% | -3.00% |
Current DrawdownCurrent decline from peak | -2.94% | 0.00% | -2.94% |
Average DrawdownAverage peak-to-trough decline | -8.85% | -4.60% | -4.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 3.26% | -0.24% |
Volatility
PJP vs. SPMO - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 5.33%, while Invesco S&P 500 Momentum ETF (SPMO) has a volatility of 7.35%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than SPMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | SPMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 7.35% | -2.02% |
Volatility (6M)Calculated over the trailing 6-month period | 12.02% | 14.39% | -2.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.38% | 17.64% | -1.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 19.30% | -3.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 20.31% | -1.92% |
PJP vs. SPMO - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is higher than SPMO's 0.13% expense ratio.
Dividends
PJP vs. SPMO - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.99%, more than SPMO's 0.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 0.99% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
SPMO Invesco S&P 500 Momentum ETF | 0.65% | 0.73% | 0.48% | 1.63% | 1.66% | 0.52% | 1.27% | 1.39% | 1.05% | 0.77% | 1.94% | 0.36% |
Frequently Asked Questions
PJP and SPMO have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SPMO has higher volatility (7.35%) compared to PJP (5.33%). In terms of maximum drawdown, PJP dropped -37.06% vs SPMO's -30.95%.
On 10-year performance, SPMO leads with 20.95% vs 6.15% for PJP. On fees, SPMO is cheaper at 0.13% per year. On volatility, PJP has been the lower-risk option at 5.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPMO has performed better with a 20.95% return vs 6.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPMO is cheaper with a 0.13% expense ratio, compared with 0.58% for PJP.
PJP has the higher dividend yield at 0.99%, compared with 0.65% for SPMO.
PJP is categorized as Health & Biotech Equities, while SPMO is Momentum. PJP tracks Dynamic Pharmaceuticals Intellidex Index, while SPMO tracks S&P 500 Momentum Index. Their fees differ too: 0.58% for PJP and 0.13% for SPMO.
SPMO currently has the higher Sharpe Ratio (2.62 vs 2.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PJP and SPMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer